Bidram E - Search Results

1

Reconstituted Keratin Biomaterial with Enhanced Ductility.

Atri H, Bidram E, Dunstan DE. Atri H, et al. Among authors: bidram e. Materials (Basel). 2015 Nov 5;8(11):7472-7485. doi: 10.3390/ma8115392. Materials (Basel). 2015. PMID: 28793650 Free PMC article.

2

Targeted Graphene Oxide Networks: Cytotoxicity and Synergy with Anticancer Agents.

Bidram E, Sulistio A, Cho HJ, Amini A, Harris T, Zarrabi A, Qiao G, Stewart A, Dunstan DE. Bidram E, et al. ACS Appl Mater Interfaces. 2018 Dec 19;10(50):43523-43532. doi: 10.1021/acsami.8b17531. Epub 2018 Dec 7. ACS Appl Mater Interfaces. 2018. PMID: 30495922

3

Hierarchical multifunctional graphene oxide cancer nanotheranostics agent for synchronous switchable fluorescence imaging and chemical therapy.

Esmaeili Y, Zarrabi A, Mirahmadi-Zare SZ, Bidram E. Esmaeili Y, et al. Among authors: bidram e. Mikrochim Acta. 2020 Sep 9;187(10):553. doi: 10.1007/s00604-020-04490-6. Mikrochim Acta. 2020. PMID: 32902688

4

Graphene oxide and its derivatives as promising In-vitro bio-imaging platforms.

Esmaeili Y, Bidram E, Zarrabi A, Amini A, Cheng C. Esmaeili Y, et al. Among authors: bidram e. Sci Rep. 2020 Oct 22;10(1):18052. doi: 10.1038/s41598-020-75090-w. Sci Rep. 2020. PMID: 33093483 Free PMC article.

5

Author Correction: Graphene oxide and its derivatives as promising In-vitro bio-imaging platforms.

Esmaeili Y, Bidram E, Zarrabi A, Amini A, Cheng C. Esmaeili Y, et al. Among authors: bidram e. Sci Rep. 2021 Apr 21;11(1):9071. doi: 10.1038/s41598-021-88760-0. Sci Rep. 2021. PMID: 33883679 Free PMC article. No abstract available.

6

Graphene oxide quantum dot-chitosan nanotheranostic platform as a pH-responsive carrier for improving curcumin uptake internalization: In vitro & in silico study.

Esmaeili Y, Seyedhosseini Ghaheh H, Ghasemi F, Shariati L, Rafienia M, Bidram E, Zarrabi A. Esmaeili Y, et al. Among authors: bidram e. Biomater Adv. 2022 Aug;139:213017. doi: 10.1016/j.bioadv.2022.213017. Epub 2022 Jul 6. Biomater Adv. 2022. PMID: 35882115

7

Organoid technology: Current standing and future perspectives.

Shariati L, Esmaeili Y, Haghjooy Javanmard S, Bidram E, Amini A. Shariati L, et al. Among authors: bidram e. Stem Cells. 2021 Dec;39(12):1625-1649. doi: 10.1002/stem.3379. Epub 2021 Sep 30. Stem Cells. 2021. PMID: 33786925 Review.

8

Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside.

Bidram E, Esmaeili Y, Amini A, Sartorius R, Tay FR, Shariati L, Makvandi P. Bidram E, et al. ACS Biomater Sci Eng. 2021 Jun 14;7(6):2150-2176. doi: 10.1021/acsbiomaterials.1c00318. Epub 2021 May 12. ACS Biomater Sci Eng. 2021. PMID: 33979143 Free PMC article. Review.

9

Mesoporous silica@chitosan@gold nanoparticles as "on/off" optical biosensor and pH-sensitive theranostic platform against cancer.

Esmaeili Y, Khavani M, Bigham A, Sanati A, Bidram E, Shariati L, Zarrabi A, Jolfaie NA, Rafienia M. Esmaeili Y, et al. Among authors: bidram e. Int J Biol Macromol. 2022 Mar 31;202:241-255. doi: 10.1016/j.ijbiomac.2022.01.063. Epub 2022 Jan 15. Int J Biol Macromol. 2022. PMID: 35041881

10

Gene Editing-Based Technologies for Beta-hemoglobinopathies Treatment.

Rahimmanesh I, Boshtam M, Kouhpayeh S, Khanahmad H, Dabiri A, Ahangarzadeh S, Esmaeili Y, Bidram E, Vaseghi G, Haghjooy Javanmard S, Shariati L, Zarrabi A, Varma RS. Rahimmanesh I, et al. Among authors: bidram e. Biology (Basel). 2022 Jun 4;11(6):862. doi: 10.3390/biology11060862. Biology (Basel). 2022. PMID: 35741383 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page